Cargando…

Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis

The emerging issues nowadays are non-alcoholic fatty liver disease (NAFLD) and its advanced stage non-alcoholic steatohepatitis (NASH), which further can be a predisposing factor for chronic liver complications, such as cirrhosis and/or development of hepatocellular carcinoma (HCC). Liver lipotoxici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Branković, Marija, Jovanović, Igor, Dukić, Marija, Radonjić, Tijana, Oprić, Svetlana, Klašnja, Slobodan, Zdravković, Marija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105530/ https://www.ncbi.nlm.nih.gov/pubmed/35563534 http://dx.doi.org/10.3390/ijms23095146

Ejemplares similares

Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease
por: Dukić, Marija, et al.
Publicado: (2023)

Point-of-Care Abdominal Ultrasonography (POCUS) on the Way to the Right and Rapid Diagnosis
por: Radonjić, Tijana, et al.
Publicado: (2022)

Aging of Liver in Its Different Diseases
por: Radonjić, Tijana, et al.
Publicado: (2022)

Elevated Transaminases as Predictors of COVID-19 Pneumonia Severity
por: Radonjić, Tijana, et al.
Publicado: (2022)

Factors Predicting Malignant Occurrence and Polyp Recurrence after the Endoscopic Resection of Large Colorectal Polyps: A Single Center Experience
por: Mandic, Olga, et al.
Publicado: (2022)

Point-of-Care Echocardiographic Characteristics of COVID-19 Patients with Pulmonary Embolism
por: Klasnja, Slobodan, et al.
Publicado: (2022)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
por: Armstrong, Matthew J., et al.
Publicado: (2016)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
por: Mendez-Sanchez, Nahum, et al.
Publicado: (2018)

Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy
por: Popadic, Viseslav, et al.
Publicado: (2021)

Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score
por: Zdravkovic, Marija, et al.
Publicado: (2021)

Cardiac Magnetic Resonance in Hypertensive Heart Disease: Time for a New Chapter
por: Zdravkovic, Marija, et al.
Publicado: (2022)

COVID-19 Vaccination Willingness and Vaccine Uptake among Healthcare Workers: A Single-Center Experience
por: Zdravkovic, Marija, et al.
Publicado: (2022)

The Predictive Value of Risk Factors and Prognostic Scores in Hospitalized COVID-19 Patients
por: Brajkovic, Milica, et al.
Publicado: (2023)

Incidence and Risk Factors for Clostridioides difficile Infections in Non-COVID and COVID-19 Patients: Experience from a Tertiary Care Hospital
por: Markovic-Denic, Ljiljana, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and lipotoxicity
por: Wasilewska, Natalia, et al.
Publicado: (2021)

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
por: Geng, Yana, et al.
Publicado: (2021)

Correlation of Dyslipidemia and Inflammation With Obstructive Sleep Apnea Severity
por: Popadic, Viseslav, et al.
Publicado: (2022)

Who Believes in ESP: Cognitive and Motivational Determinants of the Belief in Extra-Sensory Perception
por: Branković, Marija
Publicado: (2019)

D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia
por: Milenkovic, Marija, et al.
Publicado: (2022)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease
por: Filipovic, Branka, et al.
Publicado: (2021)

Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice
por: Zhou, Mei, et al.
Publicado: (2017)

All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma
por: van Mourik, Hester, et al.
Publicado: (2022)

Bradykinin and Galectin-3 in Survived and Deceased Patients with COVID-19 Pneumonia: An Increasingly Promising Biochemical Target
por: Turnic, Tamara Nikolic, et al.
Publicado: (2022)

Lipids and Antiplatelet Therapy: Important Considerations and Future Perspectives
por: Đukanović, Nina, et al.
Publicado: (2021)

Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
por: Brar, Gurmehr, et al.
Publicado: (2019)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
por: Habig, Gregory, et al.
Publicado: (2021)

A Need for Improvement in the Definition of Resistant Arterial Hypertension
por: Koracevic, Goran, et al.
Publicado: (2023)

Exploring the Importance of Health Literacy for the Quality of Life in Patients with Heart Failure
por: Jovanić, Marija, et al.
Publicado: (2018)

Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options
por: Milic, Sandra, et al.
Publicado: (2015)

Obstructive jaundice and cholangitis caused by an arterial ring of the proper hepatic artery around the common bile duct
por: Bilanovic, Dragoljub, et al.
Publicado: (2011)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis
por: Povero, Davide, et al.
Publicado: (2016)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
por: Ramai, Daryl, et al.
Publicado: (2021)

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
por: Lee, Kuei-Chuan, et al.
Publicado: (2023)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis
por: Cannito, Stefania, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vfi40r2m8kp0s70h3aoe8urihi